Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Jul. 31, 2018	Jul. 31, 2017
Cash Flows from Operating Activities:
Net income	$ 5,815,183	$ 10,673,631
Adjustments to reconcile net income to net cash provided by operations:
Depreciation and amortization	6,901,354	7,094,707
Change in fair value of commodity derivative instruments	(673,356)	(461,723)
Gain on sale of assets	(24,815)	(95,300)
Changes in operating assets and liabilities:
Restricted cash	(57,725)	(144,345)
Commodity derivative instruments	393,036	1,379,267
Accounts receivable	4,982,459	4,467,030
Inventory	(378,434)	5,442,490
Prepaid expenses and other current assets	(254,229)	(239,726)
Accounts payable	(2,689,205)	(5,299,721)
Accrued expenses	(112,357)	(452,731)
Net Cash Provided by Operating Activities	13,901,911	22,363,579
Cash Flows from Investing Activities:
Purchase of investment	(2,000,000)	(750,000)
Payments for capital expenditures	(1,809,052)	(1,721,541)
Proceeds from disposal of assets	24,815	95,300
Net Cash Used in Investing Activities	(3,784,237)	(2,376,241)
Cash Flows from Financing Activities:
Payments on long-term debt	(280,082)	(324,994)
Checks drawn in excess of bank balance		(1,866,683)
Purchase of subsidiary units attributable to non-controlling interest		(46,644)
Distributions to non-controlling interests	(4,311,192)
Member distributions paid	(11,779,102)	(11,171,190)
Net Cash Used in Financing Activities	(16,370,376)	(13,409,511)
Net Increase (Decrease) in Cash	(6,252,702)	6,577,827
Cash - Beginning of Period	21,658,422	13,797,857
Cash - End of Period	15,405,720	20,375,684
Cash paid during the period for:
Interest expense	360,228	162,295
Supplemental Disclosure of Noncash Investing and Financing Activities
Capital expenditures and construction in process included in accounts payable	$ 1,249,128	$ 88,534